DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

abrdn plc's Holding History (CIK: 0001716774)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 2,032,967 Value ($000) $33,564 Avg Close $16.88 Range $13.75 - $20.61

Q3 2025

Shares 1,113,586 Value ($000) $16,169 Avg Close $14.37 Range $12.58 - $16.20

Q2 2025

Shares 902,751 Value ($000) $12,629 Avg Close $14.07 Range $10.57 - $16.97

Q1 2025

Shares 759,815 Value ($000) $10,330 Avg Close $19.16 Range $13.30 - $24.34

Q4 2024

Shares 402,282 Value ($000) $8,199 Avg Close $25.60 Range $19.93 - $33.33

Q3 2024

Shares 363,679 Value ($000) $10,594 Avg Close $24.79 Range $19.74 - $32.13

Q2 2024

Shares 573,035 Value ($000) $13,306 Avg Close $19.20 Range $14.56 - $23.87

Q1 2024

Shares 516,019 Value ($000) $10,589 Avg Close $18.79 Range $15.49 - $23.52

Q4 2023

Shares 324,829 Value ($000) $6,971 Avg Close $19.81 Range $15.45 - $23.81

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	2,032,967	$33,564	$16.88	$13.75 - $20.61
Q3 2025	1,113,586	$16,169	$14.37	$12.58 - $16.20
Q2 2025	902,751	$12,629	$14.07	$10.57 - $16.97
Q1 2025	759,815	$10,330	$19.16	$13.30 - $24.34
Q4 2024	402,282	$8,199	$25.60	$19.93 - $33.33
Q3 2024	363,679	$10,594	$24.79	$19.74 - $32.13
Q2 2024	573,035	$13,306	$19.20	$14.56 - $23.87
Q1 2024	516,019	$10,589	$18.79	$15.49 - $23.52
Q4 2023	324,829	$6,971	$19.81	$15.45 - $23.81